Substance use. Mental and behavioural disorders due to psychoactive substance use
Conditions
Interventions
Intervention 1: Control group will receive no manipulation. Intervention 2: Four sessions of brief CBT (Baker’s manual at NDARC), consisting of a motivational interview and skills training in avoidanc
Behavior
Control group will receive no manipulation.
Four sessions of brief CBT (Baker’s manual at NDARC), consisting of a motivational interview and skills training in avoidance of high risk situations, coping with craving and relapse prevention will b
Sponsors
National Drug and Alcohol Research Centre (NDARC), University of New South Wales
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: be aged between 18 and 60 years old; report regular methamphetamine use (score of at least 0.14 in OTI methamphetamine section); meet DSM.IV-TR criteria for heroin dependence before entry to MMT; using any route of methamphetamine such as smoking, injection and/or sniffing; be willing to provide urine specimens; be able to attend appointments throughout the trial; be in MMT for at least three months prior to recruitment. Exclusion criteria: report a known concurrent severe medical and/or psychiatric conditions preventing giving informed consent; report social, medical, and/or psychiatric conditions that prevent them from attending the trial or require incarceration or hospitalization during the trial period; report withdrawal and/or intoxication symptoms at the time of recruitment; have received any similar CBT related to heroin and/or methamphetamine use within the past 12 months prior to intake.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Methamphetamine use. Timepoint: 4 weeks following the end of intervention and a 3 month follow-up. Method of measurement: Opiate Treatment Index and Timeline Followback.;Severity of methamphetamine dependence. Timepoint: 4 weeks following the end of intervention and a 3 month follow-up. Method of measurement: Severity of Dependence Scale.;Stage of change for methamphetamine use. Timepoint: 4 weeks following the end of intervention and a 3 month follow-up. Method of measurement: Speed Use Ladder Questionnaire.;General Health. Timepoint: 4 weeks following the end of intervention and a 3 month follow-up. Method of measurement: General Health Questionnaire-28. | — |
Secondary
| Measure | Time frame |
|---|---|
| Benzodiazepine use. Timepoint: 4 weeks following end of intervention and a 3-month follow-up. Method of measurement: Opiate Treatment Index.;Heroin use. Timepoint: 4 weeks following end of intervention and a 3-month follow-up. Method of measurement: Opiate Treatment Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Alam-mehrjerdi
National Drug and Alcohol reserach Centre (NDARC), University of New South Wales
Outcome results
None listed